Division of Applied Food System, Major of Food Science & Technology, Seoul Women's University, Seoul 01797, Korea.
Int J Mol Sci. 2022 Apr 5;23(7):4023. doi: 10.3390/ijms23074023.
(1) Background: Synthetic amorphous silica (SAS) is widely used as a food additive and contains nano-sized particles. SAS can be produced by fumed and precipitated methods, which may possess different physiochemical properties, toxicokinetics, and oral toxicity. (2) Methods: The toxicokinetics of fumed SAS and precipitated SAS were evaluated following a single-dose oral administration in rats. The tissue distribution and fate of both SAS particles were assessed after repeated oral administration in rats for 28 d, followed by recovery period for 90 d. Their 28-d repeated oral toxicity was also evaluated. (3) Results: Precipitated SAS showed higher oral absorption than fumed SAS, but the oral absorption of both SAS particles was low (<4%), even at 2000 mg/kg. Our tissue-distribution study revealed that both SAS particles, at a high dose (2000 mg/kg), were accumulated in the liver after repeated administration for 28 d, but the increased concentrations returned to normal levels at 29 d, the first day of the recovery period. A higher distribution level of precipitated SAS than fumed SAS and decomposed particle fates of both SAS particles were found in the liver at 28 d. No significant toxicological findings were observed after 28-d oral administration, suggesting their low oral toxicity. (4) Conclusions: Different manufacturing methods of SAS can, therefore, affect its oral toxicokinetics and tissue distribution, but not oral toxicity.
(1)背景:合成无定形二氧化硅(SAS)被广泛用作食品添加剂,其中含有纳米级颗粒。SAS 可通过气相法和沉淀法生产,这两种方法可能具有不同的理化性质、毒代动力学和口服毒性。(2)方法:在大鼠单次口服给药后,评估气相法 SAS 和沉淀法 SAS 的毒代动力学。在大鼠连续口服 28 天后,评估两种 SAS 颗粒的组织分布和归宿,并在恢复期 90 天后进行评估。还评估了它们 28 天的重复口服毒性。(3)结果:沉淀法 SAS 的口服吸收高于气相法 SAS,但两种 SAS 颗粒的口服吸收均较低(<4%),即使在 2000mg/kg 剂量下也是如此。我们的组织分布研究表明,在连续给药 28 天后,两种 SAS 颗粒(高剂量 2000mg/kg)在肝脏中积累,但在恢复期的第 29 天,即第一天,增加的浓度恢复正常水平。在 28 天时,沉淀法 SAS 在肝脏中的分布水平高于气相法 SAS,且两种 SAS 颗粒的分解颗粒命运也有所不同。在 28 天的口服给药后,未观察到明显的毒理学发现,提示其口服毒性较低。(4)结论:因此,SAS 的不同制造方法可能会影响其口服毒代动力学和组织分布,但不会影响其口服毒性。